SCHEMBL8375879

SCHEMBL8375879

CN(C)C(=O)OC1=C(N)N=CCC1=CN(C)C1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.32
ITGA4 P13612 1/20 0.32
ADH1C P00326 1/20 0.31
ADH1A P07327 1/20 0.31
ACHE P22303 3/20 0.31
BCHE P06276 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8374737 0.83 RAB9A (0.34) ACHEBCHE
SCHEMBL8374755 0.79 NCEH1 (0.32) ACHE
SCHEMBL8375152 0.78 ADH1C (0.34) ADH1CADH1A
SCHEMBL8376582 0.78 ACHE (0.36) ACHEBCHE
SCHEMBL8375118 0.77 NCEH1 (0.33)
SCHEMBL8378405 0.76 NCEH1 (0.34) ACHEBCHE
Maleic Acid SCHEMBL8375868 0.76 MAPK1 (0.30) ADH1CADH1A
SCHEMBL8375130 0.75 BCHE (0.33) ACHEBCHE
SCHEMBL8375866 0.73 NCEH1 (0.33) ACHEBCHE
SCHEMBL8375131 0.70 NCEH1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed